| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |